nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—Lenalidomide—hematologic cancer	0.0931	0.139	CbGbCtD
Tenoxicam—PTGS2—Thalidomide—hematologic cancer	0.0497	0.074	CbGbCtD
Tenoxicam—PTGS1—Bortezomib—hematologic cancer	0.0482	0.0718	CbGbCtD
Tenoxicam—SLC22A8—Mercaptopurine—hematologic cancer	0.0449	0.0669	CbGbCtD
Tenoxicam—PTGS1—Thalidomide—hematologic cancer	0.042	0.0625	CbGbCtD
Tenoxicam—PTGS1—Ifosfamide—hematologic cancer	0.037	0.055	CbGbCtD
Tenoxicam—PTGS1—Imatinib—hematologic cancer	0.0353	0.0526	CbGbCtD
Tenoxicam—PTGS2—Triamcinolone—hematologic cancer	0.0344	0.0513	CbGbCtD
Tenoxicam—CYP2C9—Bexarotene—hematologic cancer	0.0316	0.0471	CbGbCtD
Tenoxicam—PTGS2—Betamethasone—hematologic cancer	0.0296	0.044	CbGbCtD
Tenoxicam—CYP2C9—Idarubicin—hematologic cancer	0.0262	0.0391	CbGbCtD
Tenoxicam—PTGS2—Cisplatin—hematologic cancer	0.0213	0.0317	CbGbCtD
Tenoxicam—PTGS2—Etoposide—hematologic cancer	0.0209	0.0311	CbGbCtD
Tenoxicam—CYP2C9—Bortezomib—hematologic cancer	0.0194	0.0289	CbGbCtD
Tenoxicam—PTGS1—Etoposide—hematologic cancer	0.0177	0.0263	CbGbCtD
Tenoxicam—PTGS2—Dexamethasone—hematologic cancer	0.0172	0.0256	CbGbCtD
Tenoxicam—CYP2C9—Thalidomide—hematologic cancer	0.0169	0.0252	CbGbCtD
Tenoxicam—CYP2C9—Teniposide—hematologic cancer	0.0161	0.024	CbGbCtD
Tenoxicam—CYP2C9—Ifosfamide—hematologic cancer	0.0149	0.0222	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—hematologic cancer	0.0147	0.0219	CbGbCtD
Tenoxicam—CYP2C9—Imatinib—hematologic cancer	0.0142	0.0212	CbGbCtD
Tenoxicam—CYP2C9—Nilotinib—hematologic cancer	0.0129	0.0192	CbGbCtD
Tenoxicam—CYP2C9—Cisplatin—hematologic cancer	0.00723	0.0108	CbGbCtD
Tenoxicam—CYP2C9—Dexamethasone—hematologic cancer	0.00584	0.0087	CbGbCtD
Tenoxicam—PTGS2—ovarian follicle—hematologic cancer	0.00531	0.42	CbGeAlD
Tenoxicam—SLC22A8—hematopoietic system—hematologic cancer	0.00113	0.0893	CbGeAlD
Tenoxicam—SLC22A8—blood—hematologic cancer	0.000749	0.0592	CbGeAlD
Tenoxicam—CYP2C9—hematopoietic system—hematologic cancer	0.000735	0.0581	CbGeAlD
Tenoxicam—PTGS1—hematopoietic system—hematologic cancer	0.000671	0.053	CbGeAlD
Tenoxicam—PTGS2—hematopoietic system—hematologic cancer	0.000641	0.0507	CbGeAlD
Tenoxicam—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000601	0.209	CbGdCrCtD
Tenoxicam—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000601	0.209	CbGdCrCtD
Tenoxicam—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000587	0.205	CbGdCrCtD
Tenoxicam—CYP2C9—blood—hematologic cancer	0.000487	0.0385	CbGeAlD
Tenoxicam—PTGS1—blood—hematologic cancer	0.000444	0.0351	CbGeAlD
Tenoxicam—PTGS2—blood—hematologic cancer	0.000425	0.0336	CbGeAlD
Tenoxicam—PTGS2—bone marrow—hematologic cancer	0.000411	0.0325	CbGeAlD
Tenoxicam—PTGS1—lung—hematologic cancer	0.000389	0.0308	CbGeAlD
Tenoxicam—PTGS2—lung—hematologic cancer	0.000372	0.0294	CbGeAlD
Tenoxicam—PTGS1—testis—hematologic cancer	0.000367	0.029	CbGeAlD
Tenoxicam—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000363	0.126	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000363	0.126	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000354	0.124	CbGdCrCtD
Tenoxicam—PTGS1—lymph node—hematologic cancer	0.000266	0.0211	CbGeAlD
Tenoxicam—PTGS2—lymph node—hematologic cancer	0.000255	0.0201	CbGeAlD
Tenoxicam—Vomiting—Alitretinoin—hematologic cancer	6.59e-05	0.000256	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—hematologic cancer	6.57e-05	0.000256	CcSEcCtD
Tenoxicam—Anaemia—Prednisone—hematologic cancer	6.56e-05	0.000256	CcSEcCtD
Tenoxicam—Headache—Carmustine—hematologic cancer	6.55e-05	0.000255	CcSEcCtD
Tenoxicam—Dyspnoea—Triamcinolone—hematologic cancer	6.54e-05	0.000255	CcSEcCtD
Tenoxicam—Rash—Alitretinoin—hematologic cancer	6.53e-05	0.000254	CcSEcCtD
Tenoxicam—Nervous system disorder—Betamethasone—hematologic cancer	6.53e-05	0.000254	CcSEcCtD
Tenoxicam—Nervous system disorder—Dexamethasone—hematologic cancer	6.53e-05	0.000254	CcSEcCtD
Tenoxicam—Dermatitis—Alitretinoin—hematologic cancer	6.53e-05	0.000254	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	6.52e-05	0.000254	CcSEcCtD
Tenoxicam—Thrombocytopenia—Dexamethasone—hematologic cancer	6.52e-05	0.000254	CcSEcCtD
Tenoxicam—Thrombocytopenia—Betamethasone—hematologic cancer	6.52e-05	0.000254	CcSEcCtD
Tenoxicam—Vomiting—Ifosfamide—hematologic cancer	6.51e-05	0.000253	CcSEcCtD
Tenoxicam—Hypersensitivity—Cisplatin—hematologic cancer	6.5e-05	0.000253	CcSEcCtD
Tenoxicam—Headache—Alitretinoin—hematologic cancer	6.49e-05	0.000253	CcSEcCtD
Tenoxicam—Angioedema—Prednisone—hematologic cancer	6.49e-05	0.000253	CcSEcCtD
Tenoxicam—Diarrhoea—Gemcitabine—hematologic cancer	6.48e-05	0.000252	CcSEcCtD
Tenoxicam—Nausea—Thalidomide—hematologic cancer	6.47e-05	0.000252	CcSEcCtD
Tenoxicam—Dyspepsia—Triamcinolone—hematologic cancer	6.46e-05	0.000251	CcSEcCtD
Tenoxicam—Rash—Ifosfamide—hematologic cancer	6.46e-05	0.000251	CcSEcCtD
Tenoxicam—Dermatitis—Ifosfamide—hematologic cancer	6.45e-05	0.000251	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—hematologic cancer	6.45e-05	0.000251	CcSEcCtD
Tenoxicam—Dizziness—Irinotecan—hematologic cancer	6.43e-05	0.00025	CcSEcCtD
Tenoxicam—Urticaria—Etoposide—hematologic cancer	6.42e-05	0.00025	CcSEcCtD
Tenoxicam—Stomatitis—Doxorubicin—hematologic cancer	6.41e-05	0.00025	CcSEcCtD
Tenoxicam—Vertigo—Prednisone—hematologic cancer	6.38e-05	0.000248	CcSEcCtD
Tenoxicam—Hepatitis—Epirubicin—hematologic cancer	6.38e-05	0.000248	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—hematologic cancer	6.37e-05	0.000248	CcSEcCtD
Tenoxicam—Vomiting—Vincristine—hematologic cancer	6.35e-05	0.000247	CcSEcCtD
Tenoxicam—Anorexia—Dexamethasone—hematologic cancer	6.34e-05	0.000247	CcSEcCtD
Tenoxicam—Anorexia—Betamethasone—hematologic cancer	6.34e-05	0.000247	CcSEcCtD
Tenoxicam—Urticaria—Prednisolone—hematologic cancer	6.34e-05	0.000247	CcSEcCtD
Tenoxicam—Asthenia—Cisplatin—hematologic cancer	6.33e-05	0.000247	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—hematologic cancer	6.33e-05	0.000246	CcSEcCtD
Tenoxicam—Fatigue—Triamcinolone—hematologic cancer	6.32e-05	0.000246	CcSEcCtD
Tenoxicam—Urinary tract disorder—Epirubicin—hematologic cancer	6.3e-05	0.000245	CcSEcCtD
Tenoxicam—Rash—Vincristine—hematologic cancer	6.29e-05	0.000245	CcSEcCtD
Tenoxicam—Dermatitis—Vincristine—hematologic cancer	6.29e-05	0.000245	CcSEcCtD
Tenoxicam—Urethral disorder—Epirubicin—hematologic cancer	6.26e-05	0.000244	CcSEcCtD
Tenoxicam—Headache—Vincristine—hematologic cancer	6.25e-05	0.000244	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Doxorubicin—hematologic cancer	6.22e-05	0.000242	CcSEcCtD
Tenoxicam—Nausea—Carmustine—hematologic cancer	6.21e-05	0.000242	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—hematologic cancer	6.19e-05	0.000241	CcSEcCtD
Tenoxicam—Vomiting—Mitoxantrone—hematologic cancer	6.18e-05	0.000241	CcSEcCtD
Tenoxicam—Vomiting—Irinotecan—hematologic cancer	6.18e-05	0.000241	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—hematologic cancer	6.16e-05	0.00024	CcSEcCtD
Tenoxicam—Nausea—Alitretinoin—hematologic cancer	6.15e-05	0.00024	CcSEcCtD
Tenoxicam—Visual impairment—Epirubicin—hematologic cancer	6.15e-05	0.000239	CcSEcCtD
Tenoxicam—Agranulocytosis—Doxorubicin—hematologic cancer	6.14e-05	0.000239	CcSEcCtD
Tenoxicam—Rash—Irinotecan—hematologic cancer	6.13e-05	0.000239	CcSEcCtD
Tenoxicam—Rash—Mitoxantrone—hematologic cancer	6.13e-05	0.000239	CcSEcCtD
Tenoxicam—Dermatitis—Mitoxantrone—hematologic cancer	6.12e-05	0.000238	CcSEcCtD
Tenoxicam—Dermatitis—Irinotecan—hematologic cancer	6.12e-05	0.000238	CcSEcCtD
Tenoxicam—Headache—Mitoxantrone—hematologic cancer	6.09e-05	0.000237	CcSEcCtD
Tenoxicam—Headache—Irinotecan—hematologic cancer	6.09e-05	0.000237	CcSEcCtD
Tenoxicam—Nausea—Ifosfamide—hematologic cancer	6.08e-05	0.000237	CcSEcCtD
Tenoxicam—Diarrhoea—Cisplatin—hematologic cancer	6.04e-05	0.000235	CcSEcCtD
Tenoxicam—Erythema multiforme—Epirubicin—hematologic cancer	6.03e-05	0.000235	CcSEcCtD
Tenoxicam—Vomiting—Gemcitabine—hematologic cancer	6.02e-05	0.000234	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6e-05	0.000234	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—hematologic cancer	5.97e-05	0.000233	CcSEcCtD
Tenoxicam—Rash—Gemcitabine—hematologic cancer	5.97e-05	0.000233	CcSEcCtD
Tenoxicam—Dermatitis—Gemcitabine—hematologic cancer	5.97e-05	0.000232	CcSEcCtD
Tenoxicam—Eye disorder—Epirubicin—hematologic cancer	5.96e-05	0.000232	CcSEcCtD
Tenoxicam—Hypersensitivity—Etoposide—hematologic cancer	5.96e-05	0.000232	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—hematologic cancer	5.94e-05	0.000231	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—hematologic cancer	5.94e-05	0.000231	CcSEcCtD
Tenoxicam—Headache—Gemcitabine—hematologic cancer	5.93e-05	0.000231	CcSEcCtD
Tenoxicam—Nausea—Vincristine—hematologic cancer	5.93e-05	0.000231	CcSEcCtD
Tenoxicam—Cardiac disorder—Epirubicin—hematologic cancer	5.92e-05	0.000231	CcSEcCtD
Tenoxicam—Hepatitis—Doxorubicin—hematologic cancer	5.9e-05	0.00023	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisolone—hematologic cancer	5.88e-05	0.000229	CcSEcCtD
Tenoxicam—Dyspepsia—Dexamethasone—hematologic cancer	5.86e-05	0.000228	CcSEcCtD
Tenoxicam—Dyspepsia—Betamethasone—hematologic cancer	5.86e-05	0.000228	CcSEcCtD
Tenoxicam—Urinary tract disorder—Doxorubicin—hematologic cancer	5.83e-05	0.000227	CcSEcCtD
Tenoxicam—Urticaria—Triamcinolone—hematologic cancer	5.83e-05	0.000227	CcSEcCtD
Tenoxicam—Asthenia—Etoposide—hematologic cancer	5.8e-05	0.000226	CcSEcCtD
Tenoxicam—Oedema—Prednisone—hematologic cancer	5.8e-05	0.000226	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisone—hematologic cancer	5.8e-05	0.000226	CcSEcCtD
Tenoxicam—Angiopathy—Epirubicin—hematologic cancer	5.79e-05	0.000225	CcSEcCtD
Tenoxicam—Urethral disorder—Doxorubicin—hematologic cancer	5.79e-05	0.000225	CcSEcCtD
Tenoxicam—Decreased appetite—Betamethasone—hematologic cancer	5.79e-05	0.000225	CcSEcCtD
Tenoxicam—Decreased appetite—Dexamethasone—hematologic cancer	5.79e-05	0.000225	CcSEcCtD
Tenoxicam—Nausea—Mitoxantrone—hematologic cancer	5.78e-05	0.000225	CcSEcCtD
Tenoxicam—Nausea—Irinotecan—hematologic cancer	5.78e-05	0.000225	CcSEcCtD
Tenoxicam—Immune system disorder—Epirubicin—hematologic cancer	5.76e-05	0.000224	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.75e-05	0.000224	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.75e-05	0.000224	CcSEcCtD
Tenoxicam—Fatigue—Betamethasone—hematologic cancer	5.74e-05	0.000223	CcSEcCtD
Tenoxicam—Fatigue—Dexamethasone—hematologic cancer	5.74e-05	0.000223	CcSEcCtD
Tenoxicam—Pruritus—Etoposide—hematologic cancer	5.72e-05	0.000223	CcSEcCtD
Tenoxicam—Visual impairment—Doxorubicin—hematologic cancer	5.69e-05	0.000222	CcSEcCtD
Tenoxicam—Nervous system disorder—Prednisone—hematologic cancer	5.68e-05	0.000221	CcSEcCtD
Tenoxicam—Skin disorder—Prednisone—hematologic cancer	5.63e-05	0.000219	CcSEcCtD
Tenoxicam—Nausea—Gemcitabine—hematologic cancer	5.63e-05	0.000219	CcSEcCtD
Tenoxicam—Vomiting—Cisplatin—hematologic cancer	5.61e-05	0.000219	CcSEcCtD
Tenoxicam—Mental disorder—Epirubicin—hematologic cancer	5.59e-05	0.000218	CcSEcCtD
Tenoxicam—Erythema multiforme—Doxorubicin—hematologic cancer	5.58e-05	0.000217	CcSEcCtD
Tenoxicam—Rash—Cisplatin—hematologic cancer	5.57e-05	0.000217	CcSEcCtD
Tenoxicam—Dermatitis—Cisplatin—hematologic cancer	5.56e-05	0.000217	CcSEcCtD
Tenoxicam—Malnutrition—Epirubicin—hematologic cancer	5.55e-05	0.000216	CcSEcCtD
Tenoxicam—Erythema—Epirubicin—hematologic cancer	5.55e-05	0.000216	CcSEcCtD
Tenoxicam—Diarrhoea—Etoposide—hematologic cancer	5.53e-05	0.000215	CcSEcCtD
Tenoxicam—Anorexia—Prednisone—hematologic cancer	5.53e-05	0.000215	CcSEcCtD
Tenoxicam—Eye disorder—Doxorubicin—hematologic cancer	5.52e-05	0.000215	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—hematologic cancer	5.49e-05	0.000214	CcSEcCtD
Tenoxicam—Cardiac disorder—Doxorubicin—hematologic cancer	5.48e-05	0.000213	CcSEcCtD
Tenoxicam—Hypersensitivity—Triamcinolone—hematologic cancer	5.4e-05	0.00021	CcSEcCtD
Tenoxicam—Angiopathy—Doxorubicin—hematologic cancer	5.36e-05	0.000209	CcSEcCtD
Tenoxicam—Dizziness—Etoposide—hematologic cancer	5.35e-05	0.000208	CcSEcCtD
Tenoxicam—Immune system disorder—Doxorubicin—hematologic cancer	5.33e-05	0.000208	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—hematologic cancer	5.33e-05	0.000208	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—hematologic cancer	5.31e-05	0.000207	CcSEcCtD
Tenoxicam—Urticaria—Dexamethasone—hematologic cancer	5.29e-05	0.000206	CcSEcCtD
Tenoxicam—Urticaria—Betamethasone—hematologic cancer	5.29e-05	0.000206	CcSEcCtD
Tenoxicam—Dizziness—Prednisolone—hematologic cancer	5.27e-05	0.000205	CcSEcCtD
Tenoxicam—Asthenia—Triamcinolone—hematologic cancer	5.26e-05	0.000205	CcSEcCtD
Tenoxicam—Nausea—Cisplatin—hematologic cancer	5.24e-05	0.000204	CcSEcCtD
Tenoxicam—Pruritus—Triamcinolone—hematologic cancer	5.19e-05	0.000202	CcSEcCtD
Tenoxicam—Mental disorder—Doxorubicin—hematologic cancer	5.17e-05	0.000201	CcSEcCtD
Tenoxicam—Vomiting—Etoposide—hematologic cancer	5.14e-05	0.0002	CcSEcCtD
Tenoxicam—Erythema—Doxorubicin—hematologic cancer	5.14e-05	0.0002	CcSEcCtD
Tenoxicam—Malnutrition—Doxorubicin—hematologic cancer	5.14e-05	0.0002	CcSEcCtD
Tenoxicam—Anaemia—Epirubicin—hematologic cancer	5.13e-05	0.0002	CcSEcCtD
Tenoxicam—Dyspepsia—Prednisone—hematologic cancer	5.1e-05	0.000199	CcSEcCtD
Tenoxicam—Rash—Etoposide—hematologic cancer	5.1e-05	0.000199	CcSEcCtD
Tenoxicam—Dermatitis—Etoposide—hematologic cancer	5.09e-05	0.000198	CcSEcCtD
Tenoxicam—Headache—Etoposide—hematologic cancer	5.07e-05	0.000197	CcSEcCtD
Tenoxicam—Decreased appetite—Prednisone—hematologic cancer	5.04e-05	0.000196	CcSEcCtD
Tenoxicam—Rash—Prednisolone—hematologic cancer	5.03e-05	0.000196	CcSEcCtD
Tenoxicam—Dermatitis—Prednisolone—hematologic cancer	5.02e-05	0.000196	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.02e-05	0.000195	CcSEcCtD
Tenoxicam—Fatigue—Prednisone—hematologic cancer	5e-05	0.000195	CcSEcCtD
Tenoxicam—Headache—Prednisolone—hematologic cancer	5e-05	0.000195	CcSEcCtD
Tenoxicam—Vertigo—Epirubicin—hematologic cancer	4.99e-05	0.000194	CcSEcCtD
Tenoxicam—Leukopenia—Epirubicin—hematologic cancer	4.97e-05	0.000194	CcSEcCtD
Tenoxicam—Constipation—Prednisone—hematologic cancer	4.96e-05	0.000193	CcSEcCtD
Tenoxicam—Palpitations—Epirubicin—hematologic cancer	4.91e-05	0.000191	CcSEcCtD
Tenoxicam—Dizziness—Triamcinolone—hematologic cancer	4.85e-05	0.000189	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methotrexate—hematologic cancer	4.84e-05	0.000189	CcSEcCtD
Tenoxicam—Nausea—Etoposide—hematologic cancer	4.8e-05	0.000187	CcSEcCtD
Tenoxicam—Asthenia—Betamethasone—hematologic cancer	4.78e-05	0.000186	CcSEcCtD
Tenoxicam—Asthenia—Dexamethasone—hematologic cancer	4.78e-05	0.000186	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—hematologic cancer	4.75e-05	0.000185	CcSEcCtD
Tenoxicam—Anaemia—Doxorubicin—hematologic cancer	4.75e-05	0.000185	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—hematologic cancer	4.74e-05	0.000185	CcSEcCtD
Tenoxicam—Nausea—Prednisolone—hematologic cancer	4.74e-05	0.000184	CcSEcCtD
Tenoxicam—Pruritus—Dexamethasone—hematologic cancer	4.71e-05	0.000183	CcSEcCtD
Tenoxicam—Pruritus—Betamethasone—hematologic cancer	4.71e-05	0.000183	CcSEcCtD
Tenoxicam—Skin disorder—Methotrexate—hematologic cancer	4.71e-05	0.000183	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.7e-05	0.000183	CcSEcCtD
Tenoxicam—Vomiting—Triamcinolone—hematologic cancer	4.66e-05	0.000182	CcSEcCtD
Tenoxicam—Rash—Triamcinolone—hematologic cancer	4.63e-05	0.00018	CcSEcCtD
Tenoxicam—Dry mouth—Epirubicin—hematologic cancer	4.63e-05	0.00018	CcSEcCtD
Tenoxicam—Dermatitis—Triamcinolone—hematologic cancer	4.62e-05	0.00018	CcSEcCtD
Tenoxicam—Vertigo—Doxorubicin—hematologic cancer	4.62e-05	0.00018	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—hematologic cancer	4.62e-05	0.00018	CcSEcCtD
Tenoxicam—Urticaria—Prednisone—hematologic cancer	4.6e-05	0.000179	CcSEcCtD
Tenoxicam—Leukopenia—Doxorubicin—hematologic cancer	4.6e-05	0.000179	CcSEcCtD
Tenoxicam—Headache—Triamcinolone—hematologic cancer	4.6e-05	0.000179	CcSEcCtD
Tenoxicam—Diarrhoea—Dexamethasone—hematologic cancer	4.55e-05	0.000177	CcSEcCtD
Tenoxicam—Diarrhoea—Betamethasone—hematologic cancer	4.55e-05	0.000177	CcSEcCtD
Tenoxicam—Palpitations—Doxorubicin—hematologic cancer	4.54e-05	0.000177	CcSEcCtD
Tenoxicam—Anaphylactic shock—Epirubicin—hematologic cancer	4.53e-05	0.000177	CcSEcCtD
Tenoxicam—Oedema—Epirubicin—hematologic cancer	4.53e-05	0.000177	CcSEcCtD
Tenoxicam—Nervous system disorder—Epirubicin—hematologic cancer	4.45e-05	0.000173	CcSEcCtD
Tenoxicam—Thrombocytopenia—Epirubicin—hematologic cancer	4.44e-05	0.000173	CcSEcCtD
Tenoxicam—Skin disorder—Epirubicin—hematologic cancer	4.4e-05	0.000171	CcSEcCtD
Tenoxicam—Dizziness—Dexamethasone—hematologic cancer	4.4e-05	0.000171	CcSEcCtD
Tenoxicam—Dizziness—Betamethasone—hematologic cancer	4.4e-05	0.000171	CcSEcCtD
Tenoxicam—Nausea—Triamcinolone—hematologic cancer	4.36e-05	0.00017	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.35e-05	0.000169	CcSEcCtD
Tenoxicam—Anorexia—Epirubicin—hematologic cancer	4.32e-05	0.000168	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—hematologic cancer	4.32e-05	0.000168	CcSEcCtD
Tenoxicam—Dry mouth—Doxorubicin—hematologic cancer	4.28e-05	0.000167	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisone—hematologic cancer	4.27e-05	0.000166	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—hematologic cancer	4.26e-05	0.000166	CcSEcCtD
Tenoxicam—Vomiting—Dexamethasone—hematologic cancer	4.23e-05	0.000165	CcSEcCtD
Tenoxicam—Vomiting—Betamethasone—hematologic cancer	4.23e-05	0.000165	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—hematologic cancer	4.21e-05	0.000164	CcSEcCtD
Tenoxicam—Rash—Betamethasone—hematologic cancer	4.2e-05	0.000163	CcSEcCtD
Tenoxicam—Rash—Dexamethasone—hematologic cancer	4.2e-05	0.000163	CcSEcCtD
Tenoxicam—Oedema—Doxorubicin—hematologic cancer	4.19e-05	0.000163	CcSEcCtD
Tenoxicam—Anaphylactic shock—Doxorubicin—hematologic cancer	4.19e-05	0.000163	CcSEcCtD
Tenoxicam—Dermatitis—Dexamethasone—hematologic cancer	4.19e-05	0.000163	CcSEcCtD
Tenoxicam—Dermatitis—Betamethasone—hematologic cancer	4.19e-05	0.000163	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.18e-05	0.000163	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—hematologic cancer	4.18e-05	0.000163	CcSEcCtD
Tenoxicam—Headache—Dexamethasone—hematologic cancer	4.17e-05	0.000162	CcSEcCtD
Tenoxicam—Headache—Betamethasone—hematologic cancer	4.17e-05	0.000162	CcSEcCtD
Tenoxicam—Asthenia—Prednisone—hematologic cancer	4.16e-05	0.000162	CcSEcCtD
Tenoxicam—Nervous system disorder—Doxorubicin—hematologic cancer	4.11e-05	0.00016	CcSEcCtD
Tenoxicam—Thrombocytopenia—Doxorubicin—hematologic cancer	4.11e-05	0.00016	CcSEcCtD
Tenoxicam—Pruritus—Prednisone—hematologic cancer	4.1e-05	0.00016	CcSEcCtD
Tenoxicam—Skin disorder—Doxorubicin—hematologic cancer	4.07e-05	0.000159	CcSEcCtD
Tenoxicam—Dyspnoea—Epirubicin—hematologic cancer	4.04e-05	0.000157	CcSEcCtD
Tenoxicam—Anorexia—Doxorubicin—hematologic cancer	4e-05	0.000156	CcSEcCtD
Tenoxicam—Dyspepsia—Epirubicin—hematologic cancer	3.99e-05	0.000155	CcSEcCtD
Tenoxicam—Diarrhoea—Prednisone—hematologic cancer	3.97e-05	0.000154	CcSEcCtD
Tenoxicam—Nausea—Betamethasone—hematologic cancer	3.95e-05	0.000154	CcSEcCtD
Tenoxicam—Nausea—Dexamethasone—hematologic cancer	3.95e-05	0.000154	CcSEcCtD
Tenoxicam—Decreased appetite—Epirubicin—hematologic cancer	3.94e-05	0.000153	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.91e-05	0.000152	CcSEcCtD
Tenoxicam—Fatigue—Epirubicin—hematologic cancer	3.91e-05	0.000152	CcSEcCtD
Tenoxicam—Constipation—Epirubicin—hematologic cancer	3.88e-05	0.000151	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—hematologic cancer	3.85e-05	0.00015	CcSEcCtD
Tenoxicam—Dizziness—Prednisone—hematologic cancer	3.83e-05	0.000149	CcSEcCtD
Tenoxicam—Dyspnoea—Doxorubicin—hematologic cancer	3.74e-05	0.000146	CcSEcCtD
Tenoxicam—Dyspepsia—Doxorubicin—hematologic cancer	3.69e-05	0.000144	CcSEcCtD
Tenoxicam—Vomiting—Prednisone—hematologic cancer	3.69e-05	0.000143	CcSEcCtD
Tenoxicam—Rash—Prednisone—hematologic cancer	3.65e-05	0.000142	CcSEcCtD
Tenoxicam—Dermatitis—Prednisone—hematologic cancer	3.65e-05	0.000142	CcSEcCtD
Tenoxicam—Decreased appetite—Doxorubicin—hematologic cancer	3.65e-05	0.000142	CcSEcCtD
Tenoxicam—Headache—Prednisone—hematologic cancer	3.63e-05	0.000141	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.62e-05	0.000141	CcSEcCtD
Tenoxicam—Fatigue—Doxorubicin—hematologic cancer	3.62e-05	0.000141	CcSEcCtD
Tenoxicam—Urticaria—Epirubicin—hematologic cancer	3.6e-05	0.00014	CcSEcCtD
Tenoxicam—Constipation—Doxorubicin—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Tenoxicam—Hypersensitivity—Methotrexate—hematologic cancer	3.57e-05	0.000139	CcSEcCtD
Tenoxicam—Asthenia—Methotrexate—hematologic cancer	3.48e-05	0.000135	CcSEcCtD
Tenoxicam—Nausea—Prednisone—hematologic cancer	3.44e-05	0.000134	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—hematologic cancer	3.43e-05	0.000133	CcSEcCtD
Tenoxicam—Hypersensitivity—Epirubicin—hematologic cancer	3.34e-05	0.00013	CcSEcCtD
Tenoxicam—Urticaria—Doxorubicin—hematologic cancer	3.33e-05	0.00013	CcSEcCtD
Tenoxicam—Diarrhoea—Methotrexate—hematologic cancer	3.31e-05	0.000129	CcSEcCtD
Tenoxicam—Asthenia—Epirubicin—hematologic cancer	3.25e-05	0.000127	CcSEcCtD
Tenoxicam—Pruritus—Epirubicin—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Tenoxicam—Diarrhoea—Epirubicin—hematologic cancer	3.1e-05	0.000121	CcSEcCtD
Tenoxicam—Hypersensitivity—Doxorubicin—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—hematologic cancer	3.08e-05	0.00012	CcSEcCtD
Tenoxicam—Rash—Methotrexate—hematologic cancer	3.05e-05	0.000119	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—hematologic cancer	3.05e-05	0.000119	CcSEcCtD
Tenoxicam—Headache—Methotrexate—hematologic cancer	3.03e-05	0.000118	CcSEcCtD
Tenoxicam—Asthenia—Doxorubicin—hematologic cancer	3.01e-05	0.000117	CcSEcCtD
Tenoxicam—Dizziness—Epirubicin—hematologic cancer	3e-05	0.000117	CcSEcCtD
Tenoxicam—Pruritus—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Tenoxicam—Vomiting—Epirubicin—hematologic cancer	2.88e-05	0.000112	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—hematologic cancer	2.88e-05	0.000112	CcSEcCtD
Tenoxicam—Diarrhoea—Doxorubicin—hematologic cancer	2.87e-05	0.000112	CcSEcCtD
Tenoxicam—Rash—Epirubicin—hematologic cancer	2.86e-05	0.000111	CcSEcCtD
Tenoxicam—Dermatitis—Epirubicin—hematologic cancer	2.86e-05	0.000111	CcSEcCtD
Tenoxicam—Headache—Epirubicin—hematologic cancer	2.84e-05	0.000111	CcSEcCtD
Tenoxicam—Dizziness—Doxorubicin—hematologic cancer	2.77e-05	0.000108	CcSEcCtD
Tenoxicam—Nausea—Epirubicin—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Tenoxicam—Vomiting—Doxorubicin—hematologic cancer	2.67e-05	0.000104	CcSEcCtD
Tenoxicam—Rash—Doxorubicin—hematologic cancer	2.64e-05	0.000103	CcSEcCtD
Tenoxicam—Dermatitis—Doxorubicin—hematologic cancer	2.64e-05	0.000103	CcSEcCtD
Tenoxicam—Headache—Doxorubicin—hematologic cancer	2.63e-05	0.000102	CcSEcCtD
Tenoxicam—Nausea—Doxorubicin—hematologic cancer	2.49e-05	9.7e-05	CcSEcCtD
Tenoxicam—CYP2C9—Metabolism—HDC—hematologic cancer	2.05e-05	0.000363	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IDH1—hematologic cancer	2.04e-05	0.000363	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	2.03e-05	0.000361	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GSTO1—hematologic cancer	2.02e-05	0.000359	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—UGT1A1—hematologic cancer	2e-05	0.000356	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2e-05	0.000355	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—IDH2—hematologic cancer	1.99e-05	0.000354	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HMMR—hematologic cancer	1.99e-05	0.000354	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AGO2—hematologic cancer	1.98e-05	0.000351	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC9—hematologic cancer	1.96e-05	0.000348	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CRABP1—hematologic cancer	1.95e-05	0.000346	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC22A1—hematologic cancer	1.95e-05	0.000346	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—H3F3B—hematologic cancer	1.94e-05	0.000344	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.91e-05	0.000339	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALOX5—hematologic cancer	1.9e-05	0.000338	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.89e-05	0.000336	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.88e-05	0.000334	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ARNTL—hematologic cancer	1.87e-05	0.000333	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CDA—hematologic cancer	1.87e-05	0.000332	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NPM1—hematologic cancer	1.87e-05	0.000331	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NUP98—hematologic cancer	1.84e-05	0.000327	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.84e-05	0.000326	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.83e-05	0.000326	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ACP5—hematologic cancer	1.82e-05	0.000323	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA9—hematologic cancer	1.82e-05	0.000323	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PC—hematologic cancer	1.8e-05	0.00032	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOR2—hematologic cancer	1.8e-05	0.000319	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ADCY7—hematologic cancer	1.79e-05	0.000317	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NCOA3—hematologic cancer	1.79e-05	0.000317	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF19—hematologic cancer	1.79e-05	0.000317	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NUP214—hematologic cancer	1.77e-05	0.000315	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RPS14—hematologic cancer	1.77e-05	0.000315	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—DKK1—hematologic cancer	1.76e-05	0.000312	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.76e-05	0.000312	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NUP98—hematologic cancer	1.74e-05	0.00031	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT5B—hematologic cancer	1.74e-05	0.00031	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GBA—hematologic cancer	1.74e-05	0.000309	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.74e-05	0.000309	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCG2—hematologic cancer	1.74e-05	0.000309	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTR—hematologic cancer	1.74e-05	0.000309	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—IDH1—hematologic cancer	1.71e-05	0.000304	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.71e-05	0.000304	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CST3—hematologic cancer	1.71e-05	0.000303	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ENO2—hematologic cancer	1.7e-05	0.000303	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.7e-05	0.000302	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ADCY7—hematologic cancer	1.69e-05	0.000301	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTO1—hematologic cancer	1.69e-05	0.000301	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCC3—hematologic cancer	1.69e-05	0.000301	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TXN—hematologic cancer	1.69e-05	0.000301	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NUP214—hematologic cancer	1.68e-05	0.000299	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SPHK1—hematologic cancer	1.66e-05	0.000294	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—hematologic cancer	1.65e-05	0.000294	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—XIAP—hematologic cancer	1.65e-05	0.000293	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTR—hematologic cancer	1.65e-05	0.000293	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.63e-05	0.000289	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SDC1—hematologic cancer	1.62e-05	0.000287	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ENO2—hematologic cancer	1.62e-05	0.000287	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SMARCA4—hematologic cancer	1.61e-05	0.000285	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.59e-05	0.000283	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTAP—hematologic cancer	1.59e-05	0.000283	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.56e-05	0.000277	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CRABP1—hematologic cancer	1.55e-05	0.000275	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.55e-05	0.000275	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.54e-05	0.000274	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SDC1—hematologic cancer	1.53e-05	0.000272	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.52e-05	0.000271	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALOX5—hematologic cancer	1.51e-05	0.000268	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.51e-05	0.000268	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LCK—hematologic cancer	1.48e-05	0.000264	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NUP98—hematologic cancer	1.46e-05	0.00026	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.46e-05	0.000259	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—H3F3A—hematologic cancer	1.45e-05	0.000258	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ADCY7—hematologic cancer	1.42e-05	0.000252	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOA3—hematologic cancer	1.42e-05	0.000252	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—FHL2—hematologic cancer	1.42e-05	0.000252	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKCZ—hematologic cancer	1.41e-05	0.000251	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NUP214—hematologic cancer	1.41e-05	0.00025	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.39e-05	0.000248	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—AGRN—hematologic cancer	1.39e-05	0.000247	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CALR—hematologic cancer	1.39e-05	0.000247	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTR—hematologic cancer	1.38e-05	0.000245	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCG2—hematologic cancer	1.38e-05	0.000245	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NQO1—hematologic cancer	1.37e-05	0.000244	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CD44—hematologic cancer	1.37e-05	0.000244	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PARP1—hematologic cancer	1.37e-05	0.000243	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ENO2—hematologic cancer	1.35e-05	0.00024	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.35e-05	0.000239	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FBXW7—hematologic cancer	1.34e-05	0.000239	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—IDH2—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HMMR—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC2—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CXCR4—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—hematologic cancer	1.31e-05	0.000233	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD44—hematologic cancer	1.3e-05	0.000231	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYCS—hematologic cancer	1.3e-05	0.000231	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.29e-05	0.00023	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.29e-05	0.00023	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CBL—hematologic cancer	1.28e-05	0.000228	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SDC1—hematologic cancer	1.28e-05	0.000228	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.27e-05	0.000226	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.24e-05	0.000221	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.24e-05	0.00022	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.23e-05	0.000218	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HSP90AA1—hematologic cancer	1.22e-05	0.000218	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.21e-05	0.000215	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACP5—hematologic cancer	1.21e-05	0.000214	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA9—hematologic cancer	1.21e-05	0.000214	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.19e-05	0.000211	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT1—hematologic cancer	1.18e-05	0.00021	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.16e-05	0.000207	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTP1—hematologic cancer	1.15e-05	0.000204	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—IDH1—hematologic cancer	1.13e-05	0.000201	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.12e-05	0.000199	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.12e-05	0.000199	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TXN—hematologic cancer	1.12e-05	0.000199	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.11e-05	0.000197	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GRB2—hematologic cancer	1.1e-05	0.000196	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFA—hematologic cancer	1.1e-05	0.000196	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.1e-05	0.000195	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CD44—hematologic cancer	1.09e-05	0.000194	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NQO1—hematologic cancer	1.09e-05	0.000194	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KITLG—hematologic cancer	1.09e-05	0.000193	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCB1—hematologic cancer	1.08e-05	0.000193	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.07e-05	0.00019	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT5A—hematologic cancer	1.06e-05	0.000189	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.05e-05	0.000187	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NCOR1—hematologic cancer	1.05e-05	0.000187	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—hematologic cancer	1.05e-05	0.000187	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN2B—hematologic cancer	1.05e-05	0.000187	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYCS—hematologic cancer	1.03e-05	0.000183	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.03e-05	0.000182	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.03e-05	0.000182	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.03e-05	0.000182	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD86—hematologic cancer	1.02e-05	0.000181	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HES1—hematologic cancer	1e-05	0.000178	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALOX5—hematologic cancer	9.99e-06	0.000178	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NCOR1—hematologic cancer	9.98e-06	0.000177	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF1—hematologic cancer	9.87e-06	0.000175	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FOXO1—hematologic cancer	9.73e-06	0.000173	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFRB—hematologic cancer	9.71e-06	0.000173	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NUP98—hematologic cancer	9.68e-06	0.000172	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFRA—hematologic cancer	9.56e-06	0.00017	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—JAK1—hematologic cancer	9.53e-06	0.000169	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKCG—hematologic cancer	9.53e-06	0.000169	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.39e-06	0.000167	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.39e-06	0.000167	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NUP214—hematologic cancer	9.33e-06	0.000166	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTHFR—hematologic cancer	9.31e-06	0.000165	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.23e-06	0.000164	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.23e-06	0.000164	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTR—hematologic cancer	9.14e-06	0.000162	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.14e-06	0.000162	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTP1—hematologic cancer	9.1e-06	0.000162	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ENO2—hematologic cancer	8.96e-06	0.000159	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTHFR—hematologic cancer	8.82e-06	0.000157	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.8e-06	0.000156	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TERT—hematologic cancer	8.8e-06	0.000156	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HLA-A—hematologic cancer	8.8e-06	0.000156	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—hematologic cancer	8.69e-06	0.000154	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCB1—hematologic cancer	8.61e-06	0.000153	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFB—hematologic cancer	8.59e-06	0.000153	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.56e-06	0.000152	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SDC1—hematologic cancer	8.49e-06	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TSC2—hematologic cancer	8.39e-06	0.000149	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—hematologic cancer	8.36e-06	0.000149	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOR1—hematologic cancer	8.36e-06	0.000149	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.2e-06	0.000146	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.11e-06	0.000144	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGFR3—hematologic cancer	8.07e-06	0.000143	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.01e-06	0.000142	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CG—hematologic cancer	7.82e-06	0.000139	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.66e-06	0.000136	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BAD—hematologic cancer	7.65e-06	0.000136	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOTCH1—hematologic cancer	7.58e-06	0.000135	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD80—hematologic cancer	7.43e-06	0.000132	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KIT—hematologic cancer	7.41e-06	0.000132	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTHFR—hematologic cancer	7.39e-06	0.000131	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTPN11—hematologic cancer	7.28e-06	0.000129	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CREBBP—hematologic cancer	7.25e-06	0.000129	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NQO1—hematologic cancer	7.22e-06	0.000128	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CD44—hematologic cancer	7.22e-06	0.000128	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.07e-06	0.000126	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CREB1—hematologic cancer	7.06e-06	0.000125	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BRAF—hematologic cancer	6.97e-06	0.000124	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6R—hematologic cancer	6.88e-06	0.000122	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CD—hematologic cancer	6.87e-06	0.000122	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CREBBP—hematologic cancer	6.87e-06	0.000122	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYCS—hematologic cancer	6.83e-06	0.000121	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.79e-06	0.000121	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALB—hematologic cancer	6.79e-06	0.000121	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAP2K1—hematologic cancer	6.56e-06	0.000117	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CD—hematologic cancer	6.52e-06	0.000116	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.51e-06	0.000116	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.49e-06	0.000115	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF2—hematologic cancer	6.24e-06	0.000111	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CG—hematologic cancer	6.21e-06	0.00011	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3R1—hematologic cancer	6.15e-06	0.000109	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.11e-06	0.000109	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.02e-06	0.000107	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CB—hematologic cancer	5.99e-06	0.000106	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—JAK2—hematologic cancer	5.98e-06	0.000106	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MDM2—hematologic cancer	5.84e-06	0.000104	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.83e-06	0.000104	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CREBBP—hematologic cancer	5.76e-06	0.000102	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.7e-06	0.000101	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CB—hematologic cancer	5.68e-06	0.000101	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTOR—hematologic cancer	5.68e-06	0.000101	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD4—hematologic cancer	5.67e-06	0.000101	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.54e-06	9.84e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.54e-06	9.84e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.46e-06	9.7e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALB—hematologic cancer	5.39e-06	9.57e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1B—hematologic cancer	5.33e-06	9.47e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTEN—hematologic cancer	5.18e-06	9.2e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3R1—hematologic cancer	5.15e-06	9.16e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—EP300—hematologic cancer	4.94e-06	8.77e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1A—hematologic cancer	4.92e-06	8.74e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTEN—hematologic cancer	4.91e-06	8.72e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.89e-06	8.69e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CB—hematologic cancer	4.76e-06	8.45e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EP300—hematologic cancer	4.68e-06	8.32e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SRC—hematologic cancer	4.55e-06	8.09e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT3—hematologic cancer	4.39e-06	7.8e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NRAS—hematologic cancer	4.38e-06	7.78e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.31e-06	7.66e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK3—hematologic cancer	4.19e-06	7.45e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.11e-06	7.3e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTEN—hematologic cancer	4.11e-06	7.3e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—hematologic cancer	4.08e-06	7.25e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFB1—hematologic cancer	4.07e-06	7.23e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—EP300—hematologic cancer	3.92e-06	6.96e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.81e-06	6.77e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KRAS—hematologic cancer	3.77e-06	6.7e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.65e-06	6.49e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.61e-06	6.42e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALB—hematologic cancer	3.57e-06	6.34e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CA—hematologic cancer	3.46e-06	6.15e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.41e-06	6.06e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HRAS—hematologic cancer	3.2e-06	5.69e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.15e-06	5.6e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6—hematologic cancer	3.07e-06	5.45e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—AKT1—hematologic cancer	2.98e-06	5.3e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.9e-06	5.15e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKT1—hematologic cancer	2.83e-06	5.03e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTEN—hematologic cancer	2.72e-06	4.84e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—EP300—hematologic cancer	2.6e-06	4.61e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—AKT1—hematologic cancer	2.37e-06	4.21e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.92e-06	3.41e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—AKT1—hematologic cancer	1.57e-06	2.79e-05	CbGpPWpGaD
